Several registry-based randomised clinical trials (R-RCT) set up and managed by UCR were presented and discussed at the European Society of Cardiology meeting in August 2017 (ESC Congress 2017):

Oxygen therapy does not improve survival in patients with heart attack symptoms (DETO2X-AMI)
Latest Bivalirudin, Heparin face-off in MI cements winner in routine practice (VALIDATE- SWEDEHEART)

Another R-RCT managed by UCR was presented in March 2017 at the American College of Cardiology: 66th Annual Scientific Session & Expo (ACC.17):

iFR-guided strategy delivers consistent patient outcomes to an FFR-guided strategy (iFR-SWEDEHEART)

The above studies are published in the New England Journal of Medicine:


UCR is proud to contribute to increased health in Sweden and in the rest of the world.

Tillbaka till toppen
Cookies make this site work properly. By continuing to use the site, you agree that we use cookies.
Our policy on cookies and personal data OK